TOP TEN perturbations for NM_000230 (Homo sapiens)

Organism: Homo sapiens
Gene: NM_000230
Selected probe(set): 207092_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of NM_000230 (207092_at) across 5392 perturbations tested by GENEVESTIGATOR:

breast cancer study 8 (metastatic) / normal breast tissue

Relative Expression (log2-ratio):-7.8949966
Number of Samples:2 / 4
Experimental breast cancer study 8 (metastatic)
Human metastatic infiltrating ductal carcinoma sample of the breast derived from lymph nodes of a female patient with breast cancer.
Control normal breast tissue
Normal human breast samples of healthy female individuals.

breast cancer study 8 (primary) / normal breast tissue

Relative Expression (log2-ratio):-6.866679
Number of Samples:13 / 4
Experimental breast cancer study 8 (primary)
Human primary infiltrating ductal carcinoma sample of a female patient with breast cancer.
Control normal breast tissue
Normal human breast samples of healthy female individuals.

breast cancer study 15 (inv. dc) / normal breast tissue

Relative Expression (log2-ratio):-6.288145
Number of Samples:5 / 5
Experimental breast cancer study 15 (inv. dc)
Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery.
Control normal breast tissue
Tissue samples of the breast from healthy female individuals after breast reduction surgery.

breast cancer study 16 (inv. dc) / adjacent breast tissue

Relative Expression (log2-ratio):-5.3438444
Number of Samples:22 / 27
Experimental breast cancer study 16 (inv. dc)
Primary invasive ductal carcinoma tissue sample derived from the breasts of female patients after surgery.
Control adjacent breast tissue
Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer.

breast cancer study 15 (dc is) / normal breast tissue

Relative Expression (log2-ratio):-5.018033
Number of Samples:9 / 5
Experimental breast cancer study 15 (dc is)
Primary ductal carcinoma in situ tissue sample derived from the breasts of female patients after surgery.
Control normal breast tissue
Tissue samples of the breast from healthy female individuals after breast reduction surgery.

breast cancer study 11 / normal breast tissue

Relative Expression (log2-ratio):-5.0041885
Number of Samples:351 / 4
Experimental breast cancer study 11
Tissue samples from female patients with primary invasive breast cancer after surgery .
Control normal breast tissue
Tissue samples of the breast from healthy female individuals after breast reduction mammoplasty.

breast cancer study 16 (mix. inv. dc lc) / adjacent breast tissue

Relative Expression (log2-ratio):-4.856494
Number of Samples:4 / 27
Experimental breast cancer study 16 (mix. inv. dc lc)
Primary mixed invasive ductal and lobular carcinoma tissue sample derived from the breasts of female patients after surgery.
Control adjacent breast tissue
Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer.

breast cancer study 16 (inv. lc) / adjacent breast tissue

Relative Expression (log2-ratio):-4.5550346
Number of Samples:5 / 27
Experimental breast cancer study 16 (inv. lc)
Primary invasive lobular carcinoma tissue sample derived from the breasts of female patients after surgery.
Control adjacent breast tissue
Histologically normal breast tissue samples obtained from a clinically unaffected site from patients with primary invasive breast cancer.

gestational age study 1 (2nd trimester) / elective termination placenta (1st trim.) tissue

Relative Expression (log2-ratio):-4.0854053
Number of Samples:4 / 4
Experimental gestational age study 1 (2nd trimester)
Second trimester placenta samples (109-115 days) from uncomplicated elective termination.
Control elective termination placenta (1st trim.) tissue
First trimester placenta samples (45-59 days) obtained from uncomplicated elective termination.

engineered skin substitute study 1 (late) / engineered skin substitute study 1 (early)

Relative Expression (log2-ratio):3.8405771
Number of Samples:3 / 2
Experimental engineered skin substitute study 1 (late)
Human skin substitutes tissue samples collected after 14 days in culture.
Control engineered skin substitute study 1 (early)
Human skin substitutes tissue samples collected after 3 days in culture.